Hydroxyzine is the only antihistamine with a meaningful body of clinical trial evidence for treating anxiety, and it is the one most commonly prescribed for that purpose. A Cochrane systematic review found it significantly outperformed placebo for generalized anxiety disorder and performed on par with benzodiazepines and buspirone in head-to-head comparisons. Other antihistamines, including over-the-counter options like diphenhydramine (Benadryl), are sometimes used informally for their sedating effects, but they lack clinical evidence for anxiety specifically and carry risks that make them poor choices for regular use.
Why Histamine Has Anything to Do With Anxiety
Most people associate histamine with allergies, itchy eyes, and runny noses. But histamine also functions as a neurotransmitter in the brain, where it helps regulate wakefulness, appetite, cognition, and arousal.1PubMed Central. The Histaminergic System in Neuropsychiatric Disorders When you experience acute stress, histamine activity in key brain regions ramps up. Animal research has shown that this surge of brain histamine is closely linked to anxiety-related behavior, and that drugs blocking H1 histamine receptors can reduce anxiety states.2PubMed. The role of brain histamine in acute and chronic stresses That connection is why a class of drugs originally designed to block histamine in the nose and skin turns out to have calming effects in the brain as well.
The central histaminergic system is also reported to be involved in regulating broader behavioral and hormonal responses to stress, and has been implicated in mood disorders and psychosis.3PubMed. Histaminergic H1 receptors mediate L-histidine-induced anxiety in elevated plus-maze test in mice This is the biological rationale behind using an antihistamine for anxiety: if excess histamine signaling in the brain contributes to an anxious state, blocking those receptors should dial it down. Hydroxyzine does this, but it also hits serotonin and muscarinic receptors, which likely contribute to its anxiolytic profile. It is not simply a stronger version of your allergy pill.
The Evidence Behind Hydroxyzine
Hydroxyzine comes in two forms: hydroxyzine hydrochloride (Atarax) and hydroxyzine pamoate (Vistaril). Both contain the same active molecule. It has been used since the 1950s, but the rigorous trials evaluating it for generalized anxiety disorder are surprisingly few. The Cochrane review that pooled the available data found that hydroxyzine was clearly better than placebo, with treated patients roughly three times more likely to respond than those on a sugar pill.4Cochrane Database of Systematic Reviews. Hydroxyzine for generalised anxiety disorder When compared directly to benzodiazepines and buspirone, hydroxyzine performed about the same in terms of reducing anxiety symptoms and keeping patients in the trial.
One of the better individual trials enrolled 133 patients with generalized anxiety disorder and randomized them to hydroxyzine at 50 mg per day or placebo for four weeks. The hydroxyzine group showed a statistically significant drop in anxiety scores by the end of the first week. That improvement held through the full four weeks and even persisted a week after the drug was abruptly stopped, suggesting it does not produce rebound anxiety the way some sedatives can.5PubMed Central. Value of hydroxyzine in generalized anxiety disorder: controlled double-blind study versus placebo
A separate three-month trial tested hydroxyzine against both placebo and bromazepam (a benzodiazepine used widely outside the United States). Hydroxyzine produced a significantly greater reduction in anxiety rating scores compared to placebo and showed no statistically significant difference from bromazepam on any measure of efficacy.6PubMed. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study That finding matters because benzodiazepines are widely considered potent anxiolytics. Having an antihistamine perform comparably to one, without the addiction risk, is a meaningful clinical result.
Why Clinicians Choose Hydroxyzine Over Benzodiazepines
The practical appeal of hydroxyzine boils down to its safety profile relative to benzodiazepines. Benzodiazepines are effective for anxiety but carry well-known risks: physical dependence, withdrawal seizures, cognitive impairment, and dangerous interactions with alcohol and opioids. Hydroxyzine does not produce physical dependence, and there is no evidence of a withdrawal syndrome after stopping it. You can stop it abruptly without tapering. For people with a history of substance use disorders, this is especially relevant, because benzodiazepines are generally contraindicated in that population due to their abuse potential. Hydroxyzine fills a niche as a fast-acting anxiolytic option that can be prescribed without the same concerns about misuse.
The Cochrane review noted that hydroxyzine’s tolerability was roughly equivalent to that of placebo in terms of people dropping out of trials for any reason, though it did cause more drowsiness than both benzodiazepines and buspirone.7PubMed Central. Hydroxyzine for generalised anxiety disorder That drowsiness is the main side effect most people experience, and for people whose anxiety peaks at bedtime, it can actually be a feature rather than a bug. But for daytime use, it can be genuinely impairing.
What About Diphenhydramine and Other OTC Antihistamines
Diphenhydramine, the active ingredient in Benadryl and most over-the-counter sleep aids like ZzzQuil, is the antihistamine people most commonly reach for on their own when they want something calming. It does cross into the brain and block H1 receptors, and it absolutely makes you drowsy. But being sedated and having your anxiety treated are not the same thing. No randomized controlled trial has tested diphenhydramine as a standalone treatment for an anxiety disorder. Its inclusion in clinical settings tends to be as part of a sedation cocktail for acute agitation in emergency departments, where it is combined with a benzodiazepine and an antipsychotic rather than used alone for its anxiolytic properties.8Dove Medical Press (Open Access Emergency Medicine). Ketamine Versus Haloperidol/Lorazepam/Diphenhydramine Combination Treatment for Management of Acute Agitation in the Emergency Department
Self-medicating anxiety with diphenhydramine is common but problematic. The sedation wears off fairly quickly, leaving people taking repeated doses. At higher doses, diphenhydramine produces unpleasant anticholinergic effects: dry mouth, urinary retention, blurred vision, constipation, and confusion. It has stronger anticholinergic activity than hydroxyzine, which matters for long-term brain health.
Promethazine (Phenergan), another first-generation antihistamine, is occasionally prescribed off-label for its sedating effects in psychiatric settings, particularly in the UK. However, a recent critical review argued that promethazine is not suitable as a sedative for people using mental health services. The paper cited the absence of a solid evidence base, its interference with behavioral therapies that actually improve outcomes over time, underappreciated potential for recreational misuse, and an unfavorable side-effect profile.9Europe PMC. Promethazine is not a good option to aid sleep quality, especially for people using psychiatric services Second-generation antihistamines like cetirizine (Zyrtec) and loratadine (Claritin) are designed not to cross the blood-brain barrier significantly, which is why they do not make you drowsy and also why they have no role in managing anxiety.
Side Effects and Safety Concerns
Hydroxyzine’s side effects are mostly dose-dependent and predictable. Drowsiness is by far the most common, and it tends to be most pronounced in the first few days before some tolerance develops. Dry mouth, dizziness, and headache round out the usual complaints. Most people tolerate it well at standard doses of 25 to 50 mg taken up to three times daily.
The more serious concern involves the heart. Hydroxyzine can prolong the QT interval on an electrocardiogram, which in rare cases could trigger a dangerous heart rhythm called torsade de pointes. A comprehensive review of post-marketing safety data spanning six decades found 59 reported cases of QT prolongation or torsade de pointes associated with hydroxyzine. Every single one of those cases involved either an underlying medical condition, a concomitant medication that also carried QT risk, or an intentional overdose.10PubMed Central. Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug The risk is real but conditional. If you have a normal heart, take the drug at prescribed doses, and are not on other QT-prolonging medications, the absolute risk appears to be very low. Regulatory agencies in Europe have recommended limiting doses in older adults (to 50 mg per day) and avoiding it entirely in people with known QT prolongation.
The Anticholinergic Burden Question
All first-generation antihistamines, hydroxyzine included, have anticholinergic effects. Acetylcholine is a neurotransmitter critical for memory and learning, and blocking it chronically has raised concerns about long-term cognitive effects. A large cohort study of patients with allergic rhinitis found that cumulative use of first-generation antihistamines was associated with a dose-dependent increase in dementia risk. At the lowest cumulative exposure, the risk was about 13% higher than baseline. At the highest levels of cumulative exposure, the risk rose to about 50% higher.11PubMed. Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis
This kind of observational data cannot prove that antihistamines cause dementia, and there are plenty of confounding factors. But the signal is consistent with a broader body of literature on anticholinergic medications and cognitive decline in older adults. The practical takeaway is not that a short course of hydroxyzine for anxiety is going to give you dementia, but that using any first-generation antihistamine daily for years deserves a conversation with your doctor about whether a different long-term strategy makes more sense. For anxiety specifically, the goal is usually to use hydroxyzine as a bridge or as-needed tool while establishing a longer-term treatment like an SSRI or cognitive behavioral therapy.
Hydroxyzine in Children and Adolescents
Hydroxyzine is one of the few anxiolytics that gets prescribed to young children, partly because benzodiazepines are even more problematic in pediatric populations. It is commonly given before medical procedures to reduce anxiety and as a sleep aid in children with behavioral disorders. But data on the long-term neurodevelopmental effects of regular hydroxyzine use in very young children have been sparse until recently.
A population-based study examined preschool-aged children who were prescribed hydroxyzine and tracked their neurodevelopmental outcomes over time. Among children with higher cumulative exposure, there were significantly increased rates of tic disorders, anxiety disorders, and conduct disturbances compared to short-term users. Frequent users had roughly 44% higher odds of developing a tic disorder, 28% higher odds of an anxiety diagnosis, and 33% higher odds of conduct disorder compared to children who used it only briefly.12PubMed Central. Hydroxyzine Use in Preschool Children and Its Effect on Neurodevelopment: A Population-Based Longitudinal Study These are associations from observational data, not proof that hydroxyzine caused the outcomes. Children prescribed more hydroxyzine likely had more severe underlying conditions. Still, the findings are worth noting for parents whose children are on hydroxyzine regularly, because the assumption that it is completely benign in pediatric use may be premature.
The Mast Cell Connection
An emerging area of research involves people with mast cell activation syndrome, a condition in which mast cells release excessive amounts of histamine and other inflammatory mediators. Some of these patients experience psychiatric symptoms including anxiety, depression, brain fog, and panic attacks that are disproportionate to their life circumstances. Case series have documented patients whose neuropsychiatric symptoms improved with mast-cell-directed treatments, including antihistamines.13PubMed Central. Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
The theory is that abnormal mast cells in the central or peripheral nervous system, or inflammatory mediators they release into circulation, may produce neuroinflammation that manifests as psychiatric symptoms.14Brain, Behavior, & Immunity – Health. Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome For these patients, antihistamines are not treating anxiety in the traditional psychiatric sense. They are treating the underlying inflammatory process that produces anxiety as a symptom. This distinction matters because if your anxiety is driven by mast cell dysfunction, standard psychiatric medications may be less effective while H1 and H2 blockers together might provide relief that seems disproportionate to what you would expect from an allergy pill. Mast cell activation syndrome is still underdiagnosed and somewhat controversial, but it represents a genuine biological pathway by which antihistamines could relieve anxiety through a completely different mechanism than the one at work in generalized anxiety disorder.
Who Gets Prescribed Hydroxyzine in Practice
Prescription patterns for hydroxyzine reveal some interesting real-world trends. A retrospective analysis of over 13,000 primary care consultations in Poland found that women were prescribed hydroxyzine nearly three times as often as men. Prescriptions also followed a seasonal pattern, peaking in winter and dropping to their lowest point in summer for both sexes.15Taylor & Francis Online / Chronobiology International. Seasonal and daylight saving time-related variation in hydroxyzine prescribing: Evidence of circadian and environmental modulation in primary care That seasonal variation may reflect the well-documented winter increase in anxiety and insomnia, or it may partly reflect clinicians reaching for hydroxyzine when patients present with sleep complaints during darker months.
In the United States, hydroxyzine is commonly prescribed in addiction medicine clinics, psychiatric emergency departments, and primary care offices where a provider wants to offer something for acute anxiety without writing a benzodiazepine prescription. It shows up frequently in inpatient psychiatric settings as a PRN (as-needed) medication for anxiety and agitation. The drug’s versatility is a selling point: it works within 30 to 60 minutes for most people, it does not require weeks of buildup like an SSRI, and it carries minimal risk of misuse. The tradeoff is that it is not a long-term solution for most anxiety disorders and its efficacy, while real, is modest compared to the first-line treatments recommended in guidelines.
Hydroxyzine Versus SSRIs and Other Standard Treatments
If hydroxyzine works for anxiety, you might wonder why it is not the first drug everyone tries. The answer is that guidelines for generalized anxiety disorder consistently recommend SSRIs (like sertraline or escitalopram) and SNRIs (like venlafaxine or duloxetine) as first-line pharmacotherapy, with cognitive behavioral therapy as the gold standard non-drug approach. These medications have much larger evidence bases, treat the underlying disorder rather than managing symptoms episodically, and have been studied in far more patients over longer time periods.
Hydroxyzine occupies a specific niche. It works fast, which SSRIs do not. It does not cause dependence, which benzodiazepines do. It makes sense as a short-term bridge while waiting for an SSRI to take effect, as an as-needed option for breakthrough anxiety on top of a maintenance medication, or as a primary treatment for people who cannot take other anxiolytics due to substance use history. It is not the best antihistamine for anxiety because it is better than SSRIs. It is the best antihistamine for anxiety because it is the only antihistamine with actual trial data supporting that use, and it fills gaps that other drug classes leave open.
For people who find that over-the-counter diphenhydramine takes the edge off their anxiety at night, the honest advice is that hydroxyzine would likely do the same thing more effectively, with a somewhat cleaner side-effect profile, and with the added benefit of having your use monitored by a prescriber. Self-treating anxiety with OTC antihistamines is a sign you should probably be talking to someone about what is actually going on, not a sustainable management strategy.